The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Series C | Alive

Total Raised


Last Raised

$5M | 23 yrs ago

About Phase-1 Molecular Toxicology

Phase-1 Molecular Toxicology is a Healthcare/Medical Facilities & Services company based in Santa Fe, New Mexico. Phase-1 Molecular Toxicology's investors include Oxford Bioscience Partners, Gimv and Tullis Health Investors.

Phase-1 Molecular Toxicology Headquarter Location

2904 Rodeo Park Drive East Suite 300

Santa Fe, New Mexico, 87505,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • Where is Phase-1 Molecular Toxicology's headquarters?

    Phase-1 Molecular Toxicology's headquarters is located at 2904 Rodeo Park Drive East, Santa Fe.

  • What is Phase-1 Molecular Toxicology's latest funding round?

    Phase-1 Molecular Toxicology's latest funding round is Series C.

  • How much did Phase-1 Molecular Toxicology raise?

    Phase-1 Molecular Toxicology raised a total of $5M.

  • Who are the investors of Phase-1 Molecular Toxicology?

    Investors of Phase-1 Molecular Toxicology include Oxford Bioscience Partners, Tullis Health Investors and Gimv.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.